Sex |
0.180 |
0.226 |
0.647 |
0.626 |
95 |
|
Localization (stomach vs. small bowel) |
0.671 |
0.618 |
0.433 |
0.611 |
87 |
Tumour size (≥ 5 cm vs. <5 cm) |
0.005 |
0.008 |
<0.001 |
<0.001 |
92 |
Tumour size (≥ 10 cm vs. <10 cm) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
92 |
Mitotic rate (≥ 5/50 HPF vs. <5/50 HPF) |
0.001 |
0.001 |
<0.001 |
<0.001 |
90 |
Mitotic rate (≥ 10/50 HPF vs. <10/50 HPF) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
90 |
|
Histomorphology (spindle vs. not) |
0.103 |
0.099 |
0.217 |
0.187 |
92 |
|
Fletcher (high vs. non-high) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
93 |
Joensuu (high vs. non-high) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
89 |
Miettinen (high vs. non-high) |
0.001 |
<0.001 |
<0.001 |
<0.001 |
86 |
Hornick (high vs. non-high) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
90 |
Primary tumour state (unifocal vs. not) |
<0.001 |
<0.001 |
<0.001 |
-- |
93 |
|
CD34 (pos vs. neg) |
0.680 |
0.511 |
0.744 |
1.000 |
74 |
Aktin (pos vs. neg) |
1.000 |
0.818 |
0.844 |
1.000 |
64 |
Desmin (pos vs. neg) |
1.000 |
0.930 |
0.602 |
1.000 |
47 |
Cyclin H (pos vs. neg) |
0.369 |
0.189 |
0.692 |
0.806 |
95 |
|
Fletcher (high vs. non-high) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
93 |
Cyclin H (pos vs. neg, only high-risk) |
0.435 |
0.038 |
0.552 |
1.000 |
39 |
Cyclin H (pos high risk vs rest) |
0.004 |
<0.001 |
0.001 |
0.011 |
95 |
|
Joensuu (high vs. non-high) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
89 |
Cyclin H (pos vs. neg, only high-risk) |
0.281 |
0.009 |
0.330 |
0.730 |
40 |
Cyclin H (pos. high-risk vs. rest) |
0.004 |
<0.001 |
<0.001 |
0.007 |
89 |
|
Miettinen (high vs. non-high) |
0.001 |
<0.001 |
<0.001 |
<0.001 |
86 |
Cyclin H (pos vs. neg, only high-risk) |
0.681 |
0.050 |
0.967 |
0.696 |
32 |
Cyclin H (pos. high-risk vs rest) |
0.035 |
<0.001 |
0.012 |
0.053 |
86 |
|
Hornick (high vs. non-high) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
90 |
Cyclin H (pos vs. neg, only high-risk) |
0.306 |
0.020 |
0.502 |
1.000 |
36 |
Cyclin H (pos. high-risk vs. rest) |
0.003 |
<0.001 |
0.001 |
0.007 |
90 |